{"url_path":"/sec/glsi/10-k/2026/item-5","section_key":"item-5","section_title":"Item 5 MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1799788/0001493152-26-026651-index.html","accession_number":"0001493152-26-026651","cik":"0001799788","ticker":"GLSI","issuer_name":"Greenwich LifeSciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1799788/0001493152-26-026651-index.html","primary_entity_key":"0001799788","primary_entity_name":"Greenwich LifeSciences, Inc."},"word_count":105,"has_tables":true,"body_markdown":"**ITEM\n5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**\n\n \n\n**Market\ninformation**\n\n \n\nOur\ncommon stock has traded on The Nasdaq Capital Market under the symbol “GLSI” since September 25, 2020.\n\n \n\n**Number\nof Stockholders**\n\n \n\nAs\nof May 26, 2026, we had approximately 16 stockholders of record of our common stock.\n\n \n\n**Dividend\nPolicy**\n\n \n\nHistorically,\nwe have not paid any dividends to the holders of shares of our common stock and we do not expect to pay any such dividends in the foreseeable\nfuture as we expect to retain our future earnings for use in the operation and expansion of our business."}